Monocyte response in myocardial infarction in patients with type 2 diabetes

QR Code

Monocyte response in myocardial infarction in patients with type 2 diabetes

Aim. To reveal the features of monocyte response in myocardial infarction (MI) in patients with type 2 diabetes (T2D).Material and methods. The study included 121 patients with MI and T2D as follows: 76 — with target glycated hemoglobin (HbA1c), 45 — with elevated HbA1c values. In addition to the...

Full description

Saved in:

Bibliographic Details
Main Authors:	G. A. Kukharchik, O. K. Lebedeva, L. B. Gaykova
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2023-03-01
Series:	Российский кардиологический журнал
Subjects:	monocyte subpopulations inflammatory response type 2 diabetes myocardial infarction
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/5183
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

DYNAMICS OF SURFACE EXPRESSION OF TRIGGER RECEPTOR, EXPRESSED BY MYELOID CELLS-1 (TREM-1) ON VARIOUS SUBPOPULATIONS OF MONOCYTES IN EARLY POSTOPERATIVE PERIOD OF DIRECT REVASCULARIZATION OF MYOCARDIUM
by: V. G. Matveyeva, et al.
Published: (2012-05-01)

Type 2 myocardial infarction: the potential for early detection
by: V. N. Karetnikova, et al.
Published: (2023-04-01)

LIPID PEROXIDATION AND THE LEVEL OF FREE FATTY ACIDS IN PATIENTS WITH DIABETES 2ND TYPE IN INSULIN THERAPY AND INTENSIVE GLYCEMIC CONTROL IN ACUTE PHASE OF MYOCARDIAL INFARCTION
by: A. I. Fedotova, et al.
Published: (2015-04-01)

Relationships between serum HMGB1 concentration and subpopulation composition of circulating monocytes in patients with subclinical atherosclerosis
by: V. V. Genkel, et al.
Published: (2022-07-01)

Molecular genetic markers of myocardial infarction in combination with type 2 diabetes
by: A. A. Tolmacheva, et al.
Published: (2022-06-01)

MYOCARDIAL INFARCTION TYPE 2. MYTH OR REALITY?
by: V. V. Zhelnov, et al.
Published: (2016-05-01)

Monocytes and cancer: promising role as a diagnostic marker and application in therapy
by: M. R. Patysheva, et al.
Published: (2019-05-01)

Glycemia in patients with type 2 diabetes during inpatient treatment for acute myocardial infarction: impact on prognosis
by: M. A. Korotina, et al.
Published: (2021-04-01)

FOURTH UNIVERSAL DEFINITION OF MYOCARDIAL INFARCTION. FOCUS ON THE TYPE 2 MYOCARDIAL INFARCTION
by: OLGA L. Barbarash, et al.
Published: (2018-12-01)

Oxidative stress and endothelial dysfunction correction with ACE inhibitor therapy in patients with myocardial infarction and Type 2 diabetes mellitus
by: V. S. Zadionchenko, et al.
Published: (2008-10-01)

Ventricular tachycardia and myocardial infarction during antiarrhythmic therapy: a case report
by: A. A. Gurbanova, et al.
Published: (2023-07-01)

Prediction of mechanical complications post-acute myocardial infarction in individuals with type 2 diabetes mellitus
by: Changying Zhao, et al.
Published: (2025-08-01)

Prognostic Significance of Echocardiographic Characteristics in Patients with Type 2 Myocardial Infarction: comparison with Type 1 Myocardial Infarction
by: T. H. Hoang, et al.
Published: (2023-11-01)

Potential and place of efferent therapy in patients with myocardial infarction complicated by cardiogenic shock
by: M. A. Kercheva, et al.
Published: (2024-08-01)

PHARMACOTHERAPY ANALYSIS OF ACUTE ST-ELEVATION MYOCARDIAL INFARCTION IN HOSPITALS OF VARIOUS TYPES
by: R. M. Magdeev, et al.
Published: (2016-01-01)

Monocyte subpopulations of blood and bone marrow in patients with chronic heart failure
by: M. V. Vins, et al.
Published: (2018-12-01)

CLINICAL AND BIOCHEMICAL PREDICTORS OF DIABETES MELLITUS MANIFESTATION AFTER MYOCARDIAL INFARCTION
by: O. L. Barbarash, et al.
Published: (2014-03-01)

CLINICAL AND MEDICAL HISTORY FEATURES OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS WITH DIABETES MELLITUS. EPIDEMIOLOGY STUDY
by: S. A. Okrugin, et al.
Published: (2017-12-01)

THE EFFECT OF INTENSIVE GLYCEMIC CONTROL ON THE FACTORS DETERMINING PREDICTION COMPLICATIONS OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS WITH TYPE 2 DIABETES
by: A. I. Fedotova, et al.
Published: (2015-10-01)

Pro-inflammatory cytokines and depression in myocardial infarction
by: O. L. Barbarash, et al.
Published: (2011-04-01)

Monocyte chemoattractant protein-1 in patients with different types of diabetes mellitus: clinical and practical significance
by: Ivan I. Golodnikov, et al.
Published: (2025-01-01)

Differentiated approach in diagnostics, diagnosis formulation, case management and statistical accounting of type 2 myocardial infarction (Position Paper)
by: O. V. Averkov, et al.
Published: (2019-07-01)

COMPARISON OF OBESITY RELATED CARDIOMETABOLIC RISKS IN DIABETES TYPE 1 AND 2
by: N. V. Leonova, et al.
Published: (2017-05-01)

OXIDATIVE STRESS AND POSSIBILITY TO CORRECT IT WITH ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN PATIENTS WITH MYOCARDIAL INFARCTION ASSOCIATED WITH DIABETES MELLITUS TYPE 2
by: K. S. Lexina, et al.
Published: (2015-12-01)

TYPE 2 DIABETES MELLITUS AND DEPRESSION ARE PREDICTORS OF ADVERSE ANNUAL OUTCOME IN PATIENTS WITH MYOCARDIAL INFARCTION
by: Nataliay. Ardashova, et al.
Published: (2016-09-01)

MONOCYTES SUBPOPULATIONS AND CHEMILUMINESCENT ACTIVITY IN PATIENTS WITH RENAL CELL CARCINOMA
by: A. A. Savchenko, et al.
Published: (2015-04-01)

SIGNIFICANCE OF M1 AND M2 POLARIZATION OF MONOCYTES-MACROPHAGES IN THE BLOOD FOR ATHEROSCLEROSIS RISK ASSESSMENT IN TYPE 2 DIABETES COMPARING WITH CORONARY HEART DISEASE
by: К. О. Galstyan, et al.
Published: (2017-12-01)

RELATIONSHIP OF OBESITY PARAMETERS AND ADIPOKINES WITH THE RISK OF 2ND TYPE DIABETES DEVELOPMENT IN A YEAR AFTER MYOCARDIAL INFARCTION
by: O. V. Gruzdeva, et al.
Published: (2015-04-01)

PROGNOSIS IN PATIENTS WITH ST SEGMENT ELEVATION MYOCARDIAL INFARCTION, IN REGARD TO THE PRESENCE OF TYPE 2 DIABETES MELLITUS AND SELECTED TREATMENT STRATEGY IN THE ACUTE PERIOD
by: Yu. A. Belen’kova, et al.
Published: (2012-10-01)

SYSTEM FOR THE NEAREST CARDIOVASCULAR RISK ASSESSMENT IN SECOND TYPE DIABETES PATIENTS
by: N. V. Leonova, et al.
Published: (2016-04-01)

Prediction of in-hospital mortality in patients with myocardial infarction and type 2 diabetes: the role of cellular indices of systemic inflammation
by: I. F. Bokovikov, et al.
Published: (2024-08-01)

VASOSPASM AS A CAUSE OF TYPE 2 MYOCARDIAL INFARCTION. TACTICS OUTSIDE THE GUIDELINES
by: М. А. Lysenko, et al.
Published: (2017-10-01)

Pulse wave propagation rate and dynamics of matrix metalloproteinase in patients with myocardial infarction and arterial hypertension in the presence or absence of diabetes mellitus
by: V. A. Suroedov, et al.
Published: (2025-03-01)

HUMORAL AND CELLULAR IMMUNITY FACTORS IN MYOCARDIAL INFARCTION
by: V. I. Seledtsov, et al.
Published: (2014-07-01)

Features of the in-hospital course of myocardial infarction in patients with glucose metabolism disorders
by: B. U. Mardanov, et al.
Published: (2015-11-01)

Levels of proprotein convertase subtilisin/kexin type 9 in patients with acute myocardial infarction
by: A. D. Gimadeeva, et al.
Published: (2020-03-01)

THE INFLUENCE OF DIABETES MELLITUS ON THE COURSE AND OUTCOMES OF MYOCARDIAL INFARCTION IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTIONS
by: B. U. Mardanov, et al.
Published: (2016-12-01)

The role of psycho-emotional factors in assessing the prognosis of different types of myocardial infarction
by: V. I. Kinash, et al.
Published: (2024-03-01)

Subpopulations of blood monocytes in patients with generalized hypoxia
by: S. P. Chumakova, et al.
Published: (2019-05-01)

Psychosocial features of myocardial infarction patients and rehabilitation programs’ effectiveness
by: N. B. Lebedeva, et al.
Published: (2005-12-01)